Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. One Way Drug, LLC
483
•One Way Drug, LLC•May 30, 2014

One Way Drug, LLC – FDA 483, May 30, 2014

Record Details

This FDA Form 483 document details observations made during an inspection, indicating several deficiencies in the facility's operations related to drug product manufacturing, particularly concerning sterile products.

**Violations and Observations:**

1. **Sterilization Process Validation:** Procedures intended to prevent microbiological contamination of sterile drug products lack adequate validation of the sterilization process. This suggests a potential risk of non-sterile products reaching the market. 2. **Microbiological Testing:** Each batch of drug product required to be free of objectionable microorganisms is not subjected to appropriate laboratory testing. This omission means the facility cannot confirm the absence of harmful microbes in its products. 3. **Container Sterilization and Pyrogen Removal:** Drug product containers were not sterilized and processed to remove pyrogenic properties, failing to ensure their suitability for intended use. This directly impacts product safety and quality. 4. **Stability Testing Program:** A written testing program designed to assess the stability characteristics of drug products is absent. Without this, the facility cannot determine or confirm the shelf-life and potency of its products over time. 5. **Cleaning and Sanitizing Procedures:** Written procedures for the use of cleaning and sanitizing agents, crucial for preventing contamination of equipment, components, drug product containers, and drug products, are lacking. This indicates a systemic gap in contamination control. 6. **Protective Apparel:** Protective apparel is not worn as necessary to protect drug products from contamination. This observation points to a failure

Company
One Way Drug, LLC
Inspection date
May 30, 2014
Office
San Francisco District Office
People
  • Ashar P. Parikh
  • Jennifer H. Rhyu
View Company Profile

ID · 458874c5-003d-475d-9d52-b9673a4bac1f

Violation Codes6
21 CFR 211.113(b)21 CFR 211.165(b)21 CFR 211.166(a)21 CFR 211.67(b)21 CFR 211.28(a)21 CFR 211.94(c)

Full citation text and observation details available on the Dashboard.

Other documents for One Way Drug, LLC
  • 483 - 2017-07-19July 19, 2017
  • WARNING_LETTER - 2014-05-30May 30, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore One Way Drug, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.